A press release or news would be welcomed but not expected from nspx management. However, in the filings it was stated that they are working on an IND (Investigative New Drug) application for RT-AR001 and they would update this application in second half of 2021. That would mean any time between July 1 and Dec 31. So unless something unique breaks the frustration of silence may be the norm.
News 
Market Data 
Discover 
